Short-term immunotherapy: A prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis

被引:58
|
作者
Zenner, HP
Baumgarten, C
Rasp, G
Fuchs, T
Kunkel, G
Hauswald, B
Ring, J
Effendy, I
Behrendt, W
Frosch, PJ
Przybilla, B
Brunner, FX
Merk, HF
Kapp, A
Schnitker, J
Wolf, H
机构
[1] SCHERAX ARZNEIMITTEL GMBH,D-22589 HAMBURG,GERMANY
[2] UNIV TUBINGEN,HNO KLIN,TUBINGEN,GERMANY
[3] FREE UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,ABT KLIN IMMUNOL & ASTHMAPOLIKLIN,D-1000 BERLIN,GERMANY
[4] MAXIMILIANS UNIV,KLINIKUM GROSSHADERN,HNO KLIN & POLIKLIN,MUNICH,GERMANY
[5] UNIV GOTTINGEN,HAUTKLIN,D-3400 GOTTINGEN,GERMANY
[6] MED ACAD CARL GUSTAV CARUS,HNO KLIN,DRESDEN,GERMANY
[7] TECH UNIV MUNICH,DERMATOL KLIN & POLIKLIN,D-8000 MUNICH,GERMANY
[8] KLINIKUM PHILIPPS UNIV,MED ZENTRUM HAUTKRANKHEITEN,MARBURG,GERMANY
[9] UNIV LEIPZIG,HNO KLIN,D-7010 LEIPZIG,GERMANY
[10] UNIV WITTEN HERDECKE,WITTEN,GERMANY
[11] STADT KLINIKEN,HAUTKLIN,DORTMUND,GERMANY
[12] UNIV MUNICH,DERMATOL KLIN & POLIKLIN,D-80539 MUNICH,GERMANY
[13] UNIV WURZBURG,HNO KLIN & POLIKLIN,WURZBURG,GERMANY
[14] RHEIN WESTFAL TH AACHEN,HAUTKLIN,D-5100 AACHEN,GERMANY
[15] HANNOVER MED SCH,DERMATOL KLIN & POLIKLIN,HANNOVER,GERMANY
[16] INST ANGEW STAT,BIELEFELD,GERMANY
关键词
short-term immunotherapy; specific immunotherapy; allergic rhinitis; grass pollen; rye pollen; skin prick rest; specific IgE; specific IgG4;
D O I
10.1016/S0091-6749(97)70190-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Short-term immunotherapy (STI) can be beneficial for patients who are noncompliant,vith long-term specific immunotherapy. Objective: The efficacy and tolerance of STI with seven pre-seasonal injections of molecular standardized allergens from grass and rye pollen has been investigated in a double-blind, placebo-controlled multicenter study with 87 patients at 12 German University hospitals. Methods: Symptoms of the eyes, nose, and bronchi and use of symptomatic drugs were documented daily in diaries by patients with allergic rhinitis to grass and/or rye pollen and without bronchial asthma. Patients were monitored by skin prick test titration and measurement of levels of specific IgE and IgG4. Results: The median nasal score for the 10 weeks with the strongest symptoms during the gross pollen season was significantly lower (p = 0.014) with 35.0 for STI (n = 41) versus 69.0 for placebo (n = 40); the overall symptom score was 54.0 for STI versus 97.5 for placebo (p = 0.020). Only STI-treated patients exposed to less than 40 pollen grains per cubic meter per week showed a significantly lower nasal symptom score of 39.0 versus 75.0 for placebo (p = 0.006); these patients also had fewer nasal symptoms and less use of topical nasal drugs (p < 0.001). The threshold dose in skin prick tests was significantly higher, being 9.06 histamine equivalent for skin prick test (HEP) for STI-treated patients who received the maximum dose (n = 22) versus 4.33 HEP for placebo (p = 0.005). Specific IgE levels were significantly higher, being 55.9 SU/ml for STI versus 393 SU/ml for placebo after seven injections (p = 0.006) and level of specific IgG4 was 5.36% for STI versus 1.28% for placebo (p < 0.001). No severe systemic reactions were observed. Conclusion: Sn with seven preseasonal injections with molecular standardized allergens is effective and well tolerated.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [21] DOUBLE-BLIND, PLACEBO-CONTROLLED IMMUNOTHERAPY WITH MIXED GRASS-POLLEN ALLERGOIDS .1. RUSH IMMUNOTHERAPY WITH ALLERGOIDS AND STANDARDIZED ORCHARD GRASS-POLLEN EXTRACT
    BOUSQUET, J
    HEJJAOUI, A
    SKASSABROCIEK, W
    GUERIN, B
    MAASCH, HJ
    DHIVERT, H
    MICHEL, FB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 80 (04) : 591 - 598
  • [22] Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis
    Clavel, R
    Bousquet, J
    Andre, C
    ALLERGY, 1998, 53 (05) : 493 - 498
  • [23] Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double-blind placebo-controlled clinical trial
    Ahlbeck, Lars
    Ahlberg, Emelie
    Stuivers, Linn
    Bjorkander, Janne
    Nystrom, Ulla
    Retsas, Pavlos
    Govindaraj, Dhanapal
    Jenmalm, Maria C.
    Duchen, Karel
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (08): : 809 - 820
  • [24] A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen
    Rolinck-Werninghaus, C
    Wolf, H
    Liebke, C
    Baars, JC
    Lange, J
    Kopp, MV
    Hammermann, J
    Leupold, W
    Bartels, P
    Gruebl, A
    Bauer, CP
    Schnitker, J
    Wahn, U
    Niggemann, B
    ALLERGY, 2004, 59 (12) : 1285 - 1293
  • [25] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF LOCAL NASAL IMMUNOTHERAPY IN ALLERGIC RHINITIS TO PARIETARIA POLLEN
    DAMATO, G
    LOBEFALO, G
    LICCARDI, G
    CAZZOLA, M
    CLINICAL AND EXPERIMENTAL ALLERGY, 1995, 25 (02): : 141 - 148
  • [26] Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study
    Yonekura, Syuji
    Okamoto, Yoshitaka
    Sakurai, Daiju
    Iinuma, Tomohisa
    Sakurai, Toshioki
    Yoneda, Riyo
    Kurita, Junya
    Hanazawa, Toyoyuki
    Kawasaki, Yohei
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2019, 180 (04) : 274 - 283
  • [27] A Nasally Applied Cellulose Powder in Seasonal Allergic Rhinitis in Adults with Grass Pollen Allergy: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study
    Aberg, Nils
    Ospanova, S. Tetjana
    Nikitin, Nikolai P.
    Emberlin, Jean
    Dahl, Aslog
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2014, 163 (04) : 313 - 318
  • [28] Reduction of oral corticotherapy by sublingual immunotherapy (IT): Double-blind placebo-controlled study in grass pollen allergy.
    Clavel, R
    Andre, C
    Bousquet, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 197 - 197
  • [29] A prospective, randomized, double-blind placebo-controlled multi-centre dose-finding study of 3 different regimens of gpASIT plus ™ administered subcutaneously to adult patients with grass pollen-induced allergic rhinoconjunctivitis
    Zadoyan, G.
    Shah-Hosseini, K.
    Astvatsatourov, A.
    Sohlich, L.
    Kasche, Em E. M.
    Shamji, M. H.
    Durham, S. R.
    Pirotton, S.
    Legon, T.
    Moesges, R.
    ALLERGY, 2015, 70 : 41 - 42
  • [30] Can oral lactobacillus paracasei improve grass pollen allergic rhinitis?: A randomised, double-blind, placebo-controlled cross-over study
    Wassenberg, J.
    Nutten, S.
    Audran, R.
    Barbier, N.
    Chenevard, J.
    Aubert, V
    Moulin, J.
    Corthesy-Theulaz, I
    Mercenier, A.
    Spertini, F.
    ALLERGY, 2008, 63 : 84 - 85